文献速递胃肠外科围术期管理与 ERAS

手术联合广泛术中腹腔灌洗与单纯手术治疗局部晚期胃癌:SEIPLUS随机临床试验

Combined Surgery and Extensive Intraoperative Peritoneal Lavage vs Surgery Alone for Treatment of Locally Advanced Gastric Cancer: The SEIPLUS Randomized Clinical Trial.
PubMed 文献 · JAMA Surg · 2019-01-01

SEIPLUS多中心随机试验纳入662例接受D2胃切除术的晚期胃癌患者,比较手术联合广泛术中腹腔灌洗(EIPL)与单纯手术的短期结局。分析550例患者发现,联合EIPL组术后死亡率低于单纯手术组(0/279 vs 5/271,1.9%),总体并发症率(11.1% vs 17.0%)和术后疼痛(10.8% vs 17.7%)也更低。

要点

  • 联合EIPL组术后死亡0例,单纯手术组5例(1.9%),差异有统计学意义。
  • 联合EIPL组总体并发症率11.1%,低于单纯手术组的17.0%。
  • 联合EIPL组术后疼痛发生率10.8%,低于单纯手术组的17.7%。

核心结论

  • 联合EIPL可提高D2胃切除术的安全性,减少术后短期并发症和伤口疼痛。

研究设计与样本

  • 多中心随机临床试验,2016年3月至2017年11月中国11个中心纳入662例接受D2胃切除术的晚期胃癌患者,随机分为单纯手术组(329例)和手术联合EIPL组(333例)。
  • 本次分析纳入550例患者(男390例,女160例),单纯手术组平均年龄60.8(10.7)岁,联合EIPL组60.6(10.8)岁,按意向治疗人群比较短期结局。

临床怎么用

  • EIPL操作简单安全,无需特殊设备或技术,可在任何地点实施。
  • 晚期胃癌接受D2胃切除术的患者可考虑联合EIPL以降低短期并发症和疼痛。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Peritoneal metastasis is the most frequent pattern of postoperative recurrence in patients with gastric cancer. Extensive intraoperative peritoneal lavage (EIPL) is a new prophylactic strategy for treatment of peritoneal metastasis of locally advanced gastric cancer; however, the safety and efficacy of EIPL is currently unknown. OBJECTIVE: To evaluate short-term outcomes of patients with advanced gastric cancer who received combined surgery and EIPL or surgery alone. DESIGN, SETTING, AND PARTICIPANTS: From March 2016 to November 2017, 662 patients with advanced gastric cancer receiving D2 gastrectomy were enrolled in a large, multicenter, randomized clinical trial from 11 centers across China. In total, 329 patients were randomly assigned to receive surgery alone, and 333 patients were randomly assigned to receive surgery plus EIPL. Clinical characteristics, operative findings, and postoperative short-term outcomes were compared between the 2 groups in the intent-to-treat population. MAIN OUTCOMES AND MEASURES: Short-term postoperative complications and mortality. RESULTS: The present analysis included data from 550 patients, 390 men and 160 women, with a mean (SD) age of 60.8 (10.7) years in the surgery alone group and 60.6 (10.8) in the surgery plus EIPL group. Patients assigned to the surgery plus EIPL group exhibited reduced mortality (0 of 279 patients) compared with those assigned to surgery alone (5 of 271 patients [1.9%]) (difference, 1.9%; 95% CI, 0.3%-3.4%; P = .02). A significant difference in the overall postoperative complication rate was observed between patients receiving surgery alone (46 patients [17.0%]) and those receiving surgery plus EIPL (31 patients [11.1%]) (difference, 5.9%; 95% CI, 0.1%-11.6%; P = .04). Postoperative pain occurred more often following surgery alone (48 patients [17.7%]) than following surgery plus EIPL (30 patients [10.8%]) (difference, 7.0%; 95% CI, 0.8%-13.1%; P = .02). CONCLUSIONS AND RELEVANCE: Inclusion of EIPL can increase the safety of D2 gastrectomy and decrease postoperative short-term complications and wound pain. As a new, safe, and simple procedure, EIPL therapy is easily performed anywhere and does not require any special devices or techniques. Our study suggests that patients with advanced gastric cancer appear to be candidates for the EIPL approach. TRIAL REGISTRATION: ClinicalTrials.gov identifier: NCT02745509.

来源:JAMA Surg,查看原文。版权归原作者所有。

引用

  1. Guo J, Xu A, Sun X, et al. Combined Surgery and Extensive Intraoperative Peritoneal Lavage vs Surgery Alone for Treatment of Locally Advanced Gastric Cancer: The SEIPLUS Randomized Clinical Trial. JAMA Surg. 2019. PMID: 30916742. doi:10.1001/jamasurg.2019.0153

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。